TrialTrials2023

Metabolomics-based Sleepiness Markers for Risk Prevention and Traffic Safety (ME-SMART): a monocentric, controlled, randomized, crossover trial.

Michael Scholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.